# US 2026/0085339 A1 · Pathogen testing device and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085339 A1
- Document ID: US20260085339A1
- Status: Published application
- Kind: A1
- Application number: 19/112,859
- Filed: 2023-09-19
- Published: 2026-03-26
- Earliest claimed: 2022-09-19
- Assignees: RT MicroDX Inc.
- Applicants: RT MicroDX Inc.
- Inventors: David Wolf; Dylan A. Bulseco; Olivia Mamane; Prosper Wiredu Ackah; Leonid Silverman
- Web page: https://patentgrep.com/patent/US20260085339A1

## CPC

- C12Q 1/14: Streptococcus; Staphylococcus
- C12Q 1/6844: Nucleic acid amplification reactions
- B01L 3/5023: {with a sample being transported to, and subsequently stored in an absorbent for analysis}
- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- G01N 33/54388: {based on lateral flow}
- B01L 9/52: {Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips}
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/0883: Serpentine channels
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided herein is a device for detecting the presence of pathogens in a sample and methods of use thereof. The device and method comprises one or more amplification components, an indicator, and a sensor (e.g., a pH sensitive polymer). Contacting a sample with the one or more amplification components, the indicator, and the sensor (e.g., a pH sensitive polymer) in a first region of the device and subjecting the sample to an amplification method may lead to a change in pH, releasing the indicator to flow towards a second region of the device, which generates a visually detectable signal and indicates the presence of a pathogen.

## Claims

### Claim 1

A method for detecting a pathogen in a sample, comprising
subjecting a mixture comprising a sample and one or more amplification components to an amplification method in a first region of an assembly; and
contacting the sample with a pH sensor.

### Claim 2 (depends on 1)

The method of claim 1, wherein the method further comprises identifying whether a detectable signal appears in a second region of the assembly.

### Claim 3 (depends on 1)

The method of claim 1, wherein the pH sensor comprises a pH sensitive polymer encapsulating an indicator.

### Claim 4

A method for detecting a pathogen in a sample, comprising
contacting a sample with one or more amplification components in a first region of an assembly, thereby forming a mixture;
subjecting the mixture to an amplification method; and
contacting the sample with a pH sensor.

### Claim 5 (depends on 4)

The method of claim 4, wherein the method further comprises identifying whether a detectable signal appears in a second region of the assembly.

### Claim 6 (depends on 4, 5)

The method of claim 4 or 5, wherein the pH sensor comprises a pH sensitive polymer encapsulating an indicator.

### Claim 7

A method for detecting a pathogen in a sample, comprising
(a) contacting a sample with one or more amplification components in a first region of an assembly, thereby forming a mixture;
(b) subjecting the mixture to an amplification method;
(c) contacting the sample with a pH sensor; and
(d) identifying whether a detectable signal appears in a second region of the assembly.

### Claim 8 (depends on 7)

The method claim 7, wherein contacting the sample with one or more amplification components in a first region of the assembly occurs simultaneously with contacting the sample with a pH sensor, thereby forming a mixture

### Claim 9 (depends on 7, 8)

The method of claim 7 or 8, wherein the pH sensor comprises a pH sensitive polymer encapsulating an indicator.

### Claim 10

A method for detecting a pathogen in a sample, comprising
(a) contacting a sample with one or more amplification components in a first region of an assembly, thereby forming a mixture;
(b) subjecting the mixture to an amplification method;
(c) contacting the sample with a pH sensitive polymer encapsulating an indicator; and
(d) identifying whether a detectable signal appears in a second region of the assembly.

### Claim 11 (depends on 10)

The method claim 10, wherein contacting the sample with one or more amplification components in a first region of the assembly occurs simultaneously with contacting the sample with a pH sensitive polymer encapsulating an indicator, thereby forming a mixture.

### Claim 12 (depends on 7, 10)

The method of claim 7 or 10, wherein step (c) occurs after step (a).

### Claim 13 (depends on 7, 10)

The method of claim 7 or 10, wherein step (c) occurs after step (b).

### Claim 14 (depends on 7, 10)

The method of claim 7 or 10, wherein step (c) occurs prior to step (b).

### Claim 15 (depends on 7, 10)

The method of claim 7 or 10, wherein step (c) occurs prior to step (a).

### Claim 16 (depends on 7, 10)

The method of claim 7 or 10, wherein step (c) occurs simultaneously with step (a).

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The method of any one of claims 1-16, wherein detecting a signal in the second region of the assembly is indicative of the presence of a pathogen in the sample.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any one of claims 1-17, wherein the sample is a fluid sample.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any one of claims 1-17, wherein the sample is a biological sample.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any one of claims 1-17, wherein the sample is collected from a subject by the subject.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any one of claims 1-17, wherein the sample is collected from a subject by a third-party.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The method of any one of claims 1-21, wherein the sample comprises saliva.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The method of any one of claims 1-22, wherein the sample has a pH of about 6.0 to about 8.0.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The method of any one of claims 1-23, wherein the sample has a pH of about 6.0, about 6.1, about 6.2, about 6.3, about 6.4, about 6.5, about 6.6, about 6.7, about 6.8, about 6.9, about 7.0, about 7.1, about 7.2, about 7.3, about 7.4, about 7.5, about 7.6, about 7.7, about 7.8, about 7.9, or about 8.0.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 1-24, wherein the sample has a pH of about 7.0.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The method of any one of claims 1-25, wherein a buffer is added to the sample prior to contacting the sample with one or more amplification components in the first region of the assembly, thereby forming a sample solution.

### Claim 27 (depends on 26)

The method of claim 26, wherein the sample solution has a pH of about 6.0, about 6.1, about 6.2, about 6.3, about 6.4, about 6.5, about 6.6, about 6.7, about 6.8, about 6.9, about 7.0, about 7.1, about 7.2, about 7.3, about 7.4, about 7.5, about 7.6, about 7.7, about 7.8, about 7.9, or about 8.0.

### Claim 28 (depends on 27)

The method of claim 27, the sample solution has a pH of about 8.0.

### Claim 29 (depends on 26)

The method of claim 26, wherein the buffer is MOPSO buffer, PIPES buffer, imidazole buffer, MOPS buffer, BES buffer, phosphoric acid buffer, TES buffer, HEPES buffer, DIPSO buffer, TAPSO buffer, triethanolamine buffer, N-ethylmorpholine buffer, POPSO buffer, EPPS buffer, HEPPSO buffer, or Tris buffer, or a combination thereof.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any one of claims 1-29, wherein the amplification method comprises polymerase chain reaction or isothermal amplification.

### Claim 31 (depends on 30)

The method of claim 30, wherein the isothermal amplification comprises loop-mediated isothermal amplification; strand-displacement amplification; single primer isothermal amplification; strand exchange amplification; cross-priming amplification; helicase dependent amplification; rolling circle amplification; multiple displacement amplification; recombinase polymerase amplification; or nucleic acid sequence-based amplification, or any combination thereof.

### Claim 32 (depends on 31)

The method of claim 31, wherein the amplification method comprises loop-mediated isothermal amplification.

### Claim 33 (depends on 32)

The method of claim 32, wherein the amplification method comprises heating the first region of the assembly to a temperature of about 60° C. to about 70° C.

### Claim 34 (depends on 33)

The method of claim 33, wherein the amplification method comprises heating the first region of the assembly to a temperature of about 60° C., about 61° C., about 62° C., about 63° C., about 64° C., about 65° C., about 66° C., about 67° C., about 68° C., about 69° C., or about 70° C.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any one of claims 1-34, wherein the one or more amplification components comprises one or more primers.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 1-35, wherein the one or more amplification components comprises one or more outer primers.

### Claim 37 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 1-35, wherein the one or more amplification components comprises at least two outer primers.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method of any one of claims 1-37, wherein the one or more amplification components comprises one or more inner primers.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method of any one of claims 1-37, wherein the one or more amplification components comprises at least two inner primers.

### Claim 40 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The method of any one of claims 1-39, wherein the one or more amplification components comprises at least two outer primers and at least two inner primers.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The method of any one of claims 1-40, wherein the one or more amplification components comprises a forward inner primer, a backward inner primer, a forward outer primer, and a backward outer primer.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The method of any one of claims 1-41, wherein the one or more amplification components comprises one or more loop primers.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The method of any one of claims 1-41, wherein the one or more amplification components comprises at least two loop primers.

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)

The method of any one of claims 1-43, wherein the one or more amplification components comprises a forward loop primer and a backward loop primer.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The method of any one of claims 1-44, wherein the one or more amplification components comprises a forward inner primer, a backward inner primer, a forward outer primer, a backward outer primer, a forward loop primer, and a backward loop primer.

### Claim 46 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The method of any one of claims 1-45, wherein the one or more amplification components comprises a polymerase.

### Claim 47 (depends on 46)

The method of claim 46, wherein the polymerase is a DNA polymerase.

### Claim 48 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47)

The method of any one of claims 1-47, wherein the one or more amplification components comprises a reverse transcriptase.

### Claim 49 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48)

The method of any one of claims 1-48, wherein the one or more amplification components comprises a buffer.

### Claim 50 (depends on 49)

The method of claim 49, wherein the buffer is MOPSO buffer, PIPES buffer, imidazole buffer, MOPS buffer, BES buffer, phosphoric acid buffer, TES buffer, HEPES buffer, DIPSO buffer, TAPSO buffer, triethanolamine buffer, N-ethylmorpholine buffer, POPSO buffer, EPPS buffer, HEPPSO buffer, or Tris buffer, or a combination thereof.

### Claim 51 (depends on 50)

The method of claim 50, wherein the buffer is Tris buffer.

### Claim 52 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)

The method of any one of claims 1-51, wherein the one or more amplification components comprises a deoxyribonucleotide triphosphate.

### Claim 53 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)

The method of any one of claims 1-52, wherein the one or more amplification components comprises a DNA polymerase, a reverse transcriptase, a buffer, and a deoxyribonucleotide triphosphate.

### Claim 54 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The method of any one of claims 1-53, wherein the one or more amplification components comprises a magnesium salt.

### Claim 55 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The method of any one of claims 1-54, wherein the one or more amplification components comprises MgSO4.

### Claim 56 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)

The method of any one of claims 1-55, wherein the one or more amplification components comprises water.

### Claim 57 (depends on 56)

The method of claim 56, wherein the water is nuclease free water.

### Claim 58 (depends on 3, 6, 9)

The method of any one of claims 3, 6, 9, and 10-57, wherein the indicator comprises one or more of a dye, a nanoparticle, and a quantum dot.

### Claim 59 (depends on 58)

The method of claim 58, wherein the indicator comprises a nanoparticle.

### Claim 60 (depends on 59)

The method of claim 59, wherein the indicator comprises a metal nanoparticle.

### Claim 61 (depends on 60)

The method of claim 60, wherein the nanoparticle is a gold nanoparticle.

### Claim 62 (depends on 61)

The method of claim 61, wherein the gold nanoparticle has a diameter of about 2 to about 90 nm.

### Claim 63 (depends on 61)

The method of claim 61, wherein the gold nanoparticle has a diameter of about 2 to about 45 nm.

### Claim 64 (depends on 61)

The method of claim 61, wherein the gold nanoparticle has a diameter of about 5 to about 15 nm.

### Claim 65 (depends on 61)

The method of claim 61, wherein the gold nanoparticle has a diameter of about 90 nm.

### Claim 66 (depends on 61)

The method of claim 61, wherein the gold nanoparticle has a diameter of about 40 nm.

### Claim 67 (depends on 61)

The method of claim 61, wherein the gold nanoparticle has a diameter of about 10 nm.

### Claim 68 (depends on 61)

The method of claim 61, wherein the gold nanoparticle has a diameter of about 5 nm.

### Claim 69 (depends on 61)

The method of claim 61, wherein the gold nanoparticle has a diameter of about 2 nm.

### Claim 70 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69)

The method of any one of claims 1-69, wherein the indicator is conjugated to a carrier.

### Claim 71 (depends on 69)

The method claim 69, wherein the carrier is a molecule that specifically binds a protein.

### Claim 72 (depends on 70)

The method of claim 70, wherein the molecule is biotin.

### Claim 73 (depends on 70)

The method of claim 70, wherein the protein is avidin, streptavidin, or neutravidin.

### Claim 74 (depends on 3, 6, 9)

The method of any one of claims 3, 6, 9, and 10-73, wherein the pH sensitive polymer comprises natural polymer, seminatural polymer, synthetic polymer, acidic polymer, or basic polymer, or any combination thereof.

### Claim 75 (depends on 74)

The method of claim 74, wherein the pH sensitive polymer comprises chitosan, chemically modified chitosan, or any combination thereof.

### Claim 76 (depends on 75)

The method of claim 75, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is about 70% to about 100%.

### Claim 77 (depends on 75)

The method of claim 75, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is about 95%.

### Claim 78 (depends on 75)

The method of claim 75, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is greater than about 95%.

### Claim 79 (depends on 75, 76, 77, 78)

The method any one of claims 75-78, wherein the pH sensitive polymer further comprises guar gum, monoethylene glycol, poly(4-aminostyrene), poly(acrylic acid), poly(allylamine hydrochloride), poly(L-lysine hydrobromide), poly(N-methylvinylamine), poly(vinylamine) hydrochloride, polyacrylamide, polyethylene glycol, polyethylenimine, polyvinyl alcohol, starch, Type 1 collagen, nylon, poly(lactic acid), polyisoprene, or a protein, or any combination thereof.

### Claim 80 (depends on 3, 6, 9)

The method of any one of claims 3, 6, 9, and 10-79, wherein the pH sensitive polymer forms a hydrogel.

### Claim 81 (depends on 80)

The method of claim 80, wherein the pH sensitive polymer forms a hydrogel bead.

### Claim 82 (depends on 3, 6, 9)

The method of any one of claims 3, 6, 9, and 10-81, wherein the first region of the assembly comprises the one or more amplification components and the pH sensitive polymer encapsulating the indicator.

### Claim 83 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82)

The method of any one of claims 1-82, wherein the second region of the assembly comprises a lateral flow assay (LFA).

### Claim 84 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83)

The method of any one of claims 1-83, wherein the assembly is a lateral flow assay device.

### Claim 85 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84)

The method of any one of claims 1-84, wherein the sample comprises a pathogen.

### Claim 86 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85)

The method of any one of claims 1-85, wherein the amplification method changes the pH of the mixture.

### Claim 87 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86)

The method of any one of claims 1-86, wherein the amplification method changes the pH of the mixture to a pH of about 4 to about 6.8.

### Claim 88 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86)

The method of any one of claims 1-86, wherein the amplification method changes the pH of the mixture to a pH of about 5 to about 6.6.

### Claim 89 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86)

The method of any one of claims 1-86, wherein the amplification method changes the pH of the mixture to a pH of about 4, about 4.2, about 4.4, about 4.6, about 4.8, about 5.0, about 5.2, about 5.4, about 5.6, about 5.8, about 6.0, about 6.2, about 6.4, about 6.6, or about 6.8.

### Claim 90 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89)

The method of any one of claims 1-89, wherein the indicator flows to the second region of the assembly and a detectable signal appears at the second region.

### Claim 91 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90)

The method of any one of claims 1-90, wherein the pathogen is a bacteria.

### Claim 92 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91)

The method of any one of claims 1-91, wherein the pathogen is a Gram-positive bacteria.

### Claim 93 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92)

The method of any one of claims 1-92, wherein the pathogen is a Streptococcus bacteria.

### Claim 94 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93)

The method of any one of claims 1-93, wherein the pathogen is Streptococcus pyogenes.

### Claim 95

A lateral flow device for detecting a pathogen in a sample, comprising:
(a) a first region comprising one or more amplification components and a pH sensitive polymer encapsulating an indicator;
(b) an insulated chamber surrounding the first region;
(d) a heating element adjacent to the first region; and
(d) a second region comprising an agent that associates with the indicator.

### Claim 96

A lateral flow device for detecting a pathogen in a sample, comprising:
(a) a first region comprising one or more amplification components;
(b) a pH sensitive polymer encapsulating an indicator;
(c) an insulated chamber surrounding the first region;
(d) a heating element adjacent to the first region; and
(e) a second region comprising an agent that associates with the indicator.

### Claim 97 (depends on 95, 96)

The lateral flow device of claim 95 or 96, wherein the one or more amplification components comprises one or more primers.

### Claim 98 (depends on 95, 96, 97)

The lateral flow device of any one of claims 95-97, wherein the one or more amplification components comprises one or more outer primers.

### Claim 99 (depends on 95, 96, 97)

The lateral flow device of any one of claims 95-97, wherein the one or more amplification components comprises at least two outer primers.

### Claim 100 (depends on 95, 96, 97, 98, 99)

The lateral flow device of any one of claims 95-99, wherein the one or more amplification components comprises one or more inner primers.

### Claim 101 (depends on 95, 96, 97, 98, 99)

The lateral flow device of any one of claims 95-99, wherein the one or more amplification components comprises at least two inner primers.

### Claim 102 (depends on 95, 96, 97, 98, 99, 100, 101)

The lateral flow device of any one of claims 95-101, wherein the one or more amplification components comprises at least two outer primers and at least two inner primers.

### Claim 103 (depends on 95, 96, 97, 98, 99, 100, 101, 102)

The lateral flow device of any one of claims 95-102, wherein the one or more amplification components comprises a forward inner primer, a backward inner primer, a forward outer primer, and a backward outer primer.

### Claim 104 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103)

The lateral flow device of any one of claims 95-103, wherein the one or more amplification components comprises one or more loop primers.

### Claim 105 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The lateral flow device of any one of claims 95-104, wherein the one or more amplification components comprises at least two loop primers.

### Claim 106 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The lateral flow device of any one of claims 95-104, wherein the one or more amplification components comprises a forward loop primer and a backward loop primer.

### Claim 107 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106)

The lateral flow device of any one of claims 95-106, wherein the one or more amplification components comprises a forward inner primer, a backward inner primer, a forward outer primer, a backward outer primer, a forward loop primer, and a backward loop primer.

### Claim 108 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107)

The lateral flow device of any one of claims 95-107, wherein the one or more amplification components comprises a polymerase.

### Claim 109 (depends on 108)

The method of claim 108, wherein the polymerase is a DNA polymerase.

### Claim 110 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109)

The lateral flow device of any one of claims 95-109, wherein the one or more amplification components comprises a reverse transcriptase.

### Claim 111 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110)

The lateral flow device of any one of claims 95-110, wherein the one or more amplification components comprises a buffer reagent.

### Claim 112 (depends on 111)

The lateral flow device of claim 111, wherein the buffer reagent is MOPSO, PIPES, imidazole, MOPS, BES, phosphoric acid, TES, HEPES, DIPSO, TAPSO, triethanolamine, N-ethylmorpholine, POPSO, EPPS, HEPPSO, or Tris, or a salt thereof, or a combination thereof.

### Claim 113 (depends on 112)

The lateral flow device of claim 112, wherein the buffer reagent is Tris.

### Claim 114 (depends on 1, 113)

The lateral flow device of any one of claims 1-113, wherein the one or more amplification components comprises a deoxyribonucleotide triphosphate.

### Claim 115 (depends on 1, 114)

The lateral flow device of any one of claims 1-114, wherein the one or more amplification components comprises a DNA polymerase, a reverse transcriptase, a buffer reagent, and a deoxyribonucleotide triphosphate.

### Claim 116 (depends on 1, 115)

The lateral flow device of any one of claims 1-115, wherein the one or more amplification components comprises a magnesium salt.

### Claim 117 (depends on 1, 116)

The lateral flow device of any one of claims 1-116, wherein the one or more amplification components comprises MgSO4.

### Claim 118 (depends on 1, 117)

The lateral flow device of any one of claims 1-117, wherein the one or more amplification components comprises water.

### Claim 119 (depends on 118)

The lateral flow device of claim 118, wherein the water is nuclease free water.

### Claim 120 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119)

The lateral flow device of any one of claims 95-119, wherein the indicator comprises one or more of a dye, a nanoparticle, and a quantum dot.

### Claim 121 (depends on 120)

The lateral flow device of claim 120, wherein the indicator comprises a nanoparticle.

### Claim 122 (depends on 121)

The lateral flow device of claim 121, wherein the indicator comprises a metal nanoparticle.

### Claim 123 (depends on 122)

The lateral flow device of claim 122, wherein the nanoparticle is a gold nanoparticle.

### Claim 124 (depends on 123)

The lateral flow device of claim 123, wherein the gold nanoparticle is conjugated to a molecule that specifically binds the agent.

### Claim 125 (depends on 124)

The lateral flow device of claim 124, wherein the molecule is biotin.

### Claim 126 (depends on 124)

The lateral flow device of claim 124, wherein the agent is a protein.

### Claim 127 (depends on 126)

The lateral flow device of claim 126, wherein the protein is avidin, streptavidin, or neutravidin.

### Claim 128 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127)

The lateral flow device of any one of claims 95-127, wherein the pH sensitive polymer comprises natural polymer, seminatural polymer, synthetic polymer, acidic polymer, basic polymer, or any combination thereof.

### Claim 129 (depends on 128)

The lateral flow device of claim 128, wherein the pH sensitive polymer comprises chitosan, chemically modified chitosan, or any combination thereof.

### Claim 130 (depends on 129)

The lateral flow device of claim 129, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is about 70% to about 100%.

### Claim 131 (depends on 130)

The lateral flow device of claim 130, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is about 95%.

### Claim 132 (depends on 131)

The lateral flow device of claim 131, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is greater than about 95%.

### Claim 133 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132)

The lateral flow device any one of claims 95-132, wherein the pH sensitive polymer further comprises guar gum, monoethylene glycol, poly(4-aminostyrene), poly(acrylic acid), poly(allylamine hydrochloride), poly(L-lysine hydrobromide), poly(N-methylvinylamine), poly(vinylamine) hydrochloride, polyacrylamide, polyethylene glycol, polyethylenimine, polyvinyl alcohol, starch, Type 1 collagen, nylon, poly(lactic acid), polyisoprene, or a protein, or any combination thereof.

### Claim 134 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133)

The lateral flow device any one of claims 95-133, wherein the pH sensitive polymer forms a hydrogel.

### Claim 135 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134)

The lateral flow device any one of claims 95-134, wherein the pH sensitive polymer forms a hydrogel bead.

### Claim 136 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135)

The lateral flow device of any one of claims 95-135, wherein the pathogen is a bacteria.

### Claim 137 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136)

The lateral flow device of any one of claims 95-136, wherein the pathogen is a Gram-positive bacteria.

### Claim 138 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137)

The lateral flow device of any one of claims 95-137, wherein the pathogen is a Streptococcus bacteria.

### Claim 139 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The lateral flow device of any one of claims 95-138, wherein the pathogen is Streptococcus pyogenes.

### Claim 140

A composition comprising a pH sensitive polymer encapsulating an indicator.

### Claim 141 (depends on 140)

The composition of claim 140, wherein the composition further comprises one or more amplification components.

### Claim 142

A composition comprising:
(a) one or more amplification components;
(b) a pH sensitive polymer; and
(c) an indicator.

### Claim 143 (depends on 142)

The composition of claim 142, wherein the pH sensitive polymer encapsulates the indicator.

### Claim 144 (depends on 140, 141, 142, 143)

The composition of any one of claims 140-143, wherein the indicator comprises a nanoparticle.

### Claim 145 (depends on 144)

The composition of claim 144, wherein the nanoparticle is a metal nanoparticle.

### Claim 146 (depends on 145)

The composition of claim 145, wherein the nanoparticle is a gold nanoparticle.

### Claim 147 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle has a diameter of about 2 to about 90 nm.

### Claim 148 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle has a diameter of about 2 to about 45 nm

### Claim 149 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle has a diameter of about 5 to about 15 nm.

### Claim 150 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle has a diameter of about 90 nm.

### Claim 151 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle has a diameter of about 40 nm.

### Claim 152 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle has a diameter of about 10 nm.

### Claim 153 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle has a diameter of about 5 nm.

### Claim 154 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle has a diameter of about 2 nm.

### Claim 155 (depends on 145)

The composition of claim 145, wherein the gold nanoparticle is conjugated to a molecule that specifically binds a protein.

### Claim 156 (depends on 155)

The composition claim 155, wherein the molecule is biotin.

### Claim 157 (depends on 155)

The method of claim 155, wherein the protein is avidin, streptavidin, or neutravidin.

### Claim 158 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157)

The composition of any one of claims 140-157, wherein the pH sensitive polymer comprises natural polymer, seminatural polymer, synthetic polymer, acidic polymer, basic polymer, or any combination thereof.

### Claim 159 (depends on 158)

The composition of claim 158, wherein the pH sensitive polymer comprises chitosan, chemically modified chitosan, or any combination thereof.

### Claim 160 (depends on 159)

The composition of claim 159, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is about 70% to about 100%.

### Claim 161 (depends on 159)

The composition of claim 159, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is about 90%.

### Claim 162 (depends on 159)

The composition of claim 159, wherein the degree of deacetylation of the chitosan or chemically modified chitosan is greater than about 90%.

### Claim 163 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162)

The composition any one of claims 140-162, wherein the pH sensitive polymer further comprises guar gum, monoethylene glycol, poly(4-aminostyrene), poly(acrylic acid), poly(allylamine hydrochloride), poly(L-lysine hydrobromide), poly(N-methylvinylamine), poly(vinylamine) hydrochloride, polyacrylamide, polyethylene glycol, polyethylenimine, polyvinyl alcohol, starch, Type 1 collagen, nylon, poly(lactic acid), polyisoprene, or a protein, or any combination thereof.

### Claim 164 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163)

The composition of any one of claims 140-163, wherein the pH sensitive polymer forms a hydrogel.

### Claim 165 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164)

The composition of any one of claims 140-164, wherein the pH sensitive polymer forms a hydrogel bead.

### Claim 166 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165)

The composition of any one of claims 140-165, wherein the one or more amplification components comprises one or more primers.

### Claim 167 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166)

The composition of any one of claims 140-166, wherein the one or more amplification components comprises one or more outer primers.

### Claim 168 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166)

The composition of any one of claims 140-166, wherein the one or more amplification components comprises at least two outer primers.

### Claim 169 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168)

The composition of any one of claims 140-168, wherein the one or more amplification components comprises one or more inner primers.

### Claim 170 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168)

The composition of any one of claims 140-168, wherein the one or more amplification components comprises at least two inner primers.

### Claim 171 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170)

The composition of any one of claims 140-170, wherein the one or more amplification components comprises at least two outer primers and at least two inner primers.

### Claim 172 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171)

The composition of any one of claims 140-171, wherein the one or more amplification components comprises a forward inner primer, a backward inner primer, a forward outer primer, and a backward outer primer.

### Claim 173 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172)

The composition of any one of claims 140-172, wherein the one or more amplification components comprises one or more loop primers.

### Claim 174 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172)

The composition of any one of claims 140-172, wherein the one or more amplification components comprises at least two loop primers.

### Claim 175 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174)

The composition of any one of claims 140-174, wherein the one or more amplification components comprises a forward loop primer and a backward loop primer.

### Claim 176 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175)

The composition of any one of claims 140-175, wherein the one or more amplification components comprises a forward inner primer, a backward inner primer, a forward outer primer, a backward outer primer, a forward loop primer, and a backward loop primer.

### Claim 177 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176)

The composition of any one of claims 140-176, wherein the one or more amplification components comprises a polymerase.

### Claim 178 (depends on 177)

The composition of claim 177, wherein the polymerase is a DNA polymerase.

### Claim 179 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178)

The composition of any one of claims 140-178, wherein the one or more amplification components comprises a reverse transcriptase.

### Claim 180 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179)

The composition of any one of claims 140-179, wherein the one or more amplification components comprises a buffer.

### Claim 181 (depends on 180)

The composition of claim 180, wherein the buffer is MOPSO buffer, PIPES buffer, imidazole buffer, MOPS buffer, BES buffer, phosphoric acid buffer, TES buffer, HEPES buffer, DIPSO buffer, TAPSO buffer, triethanolamine buffer, N-ethylmorpholine buffer, POPSO buffer, EPPS buffer, HEPPSO buffer, or Tris buffer, or a combination thereof.

### Claim 182 (depends on 181)

The composition of claim 181, wherein the buffer is Tris buffer.

### Claim 183 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182)

The composition of any one of claims 140-182, wherein the one or more amplification components comprises a deoxyribonucleotide triphosphate.

### Claim 184 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183)

The composition of any one of claims 140-183, wherein the one or more amplification components comprises a DNA polymerase, a reverse transcriptase, a buffer, and a deoxyribonucleotide triphosphate.

### Claim 185 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184)

The composition of any one of claims 140-184, wherein the one or more amplification components comprises a magnesium salt.

### Claim 186 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185)

The composition of any one of claims 140-185, wherein the one or more amplification components comprises MgSO4.

### Claim 187 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186)

The composition of any one of claims 140-186, wherein the one or more amplification components comprises water.

### Claim 188 (depends on 187)

The composition of claim 187, wherein the water is nuclease free water.

### Claim 189 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186)

The composition of any one of claims 140-186, wherein the one or more amplification components is lyophilized.

### Claim 190 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189)

A method for detecting a pathogen in a sample, the method comprising the use of a composition of any one of claims 140-189.

### Claim 191 (depends on 190)

The method of claim 190, wherein the method comprises contacting a sample with the composition, thereby forming a mixture, and subjecting the mixture to an amplification method.

### Claim 192 (depends on 191)

The method of claim 191, wherein the amplification method comprises polymerase chain reaction or isothermal amplification.

### Claim 193 (depends on 192)

The method of claim 192, wherein the isothermal amplification comprises at least one of loop-mediated isothermal amplification; strand-displacement amplification; single primer isothermal amplification; strand exchange amplification; cross-priming amplification; helicase dependent amplification; rolling circle amplification; multiple displacement amplification; recombinase polymerase amplification; or nucleic acid sequence-based amplification.

### Claim 194 (depends on 193)

The method of claim 193, wherein the amplification method comprises loop-mediated isothermal amplification.

### Claim 195 (depends on 194)

The method of claim 194, wherein the amplification method comprises heating the first region of the assembly to a temperature of about 60° C. to about 70° C.

### Claim 196 (depends on 194)

The method of claim 194, wherein the amplification method comprises heating the first region of the assembly to a temperature of about 60° C., about 61° C., about 62° C., about 63° C., about 64° C., about 65° C., about 66° C., about 67° C., about 68° C., about 69° C., or about 70° C.

### Claim 197 (depends on 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189)

A lateral flow device for detecting a pathogen in a sample, comprising the use of a composition of any one of claims 140-189.

### Claim 198 (depends on 197)

The lateral flow device of claim 197, wherein the lateral flow device comprises a first region, an insulated chamber surrounding the first region, a heating element adjacent to the first region, and a second region,
wherein the first region comprises the composition; and
wherein the second region comprises an agent that associates with the indicator of the composition.
